Institutional investors control 9.26% of the outstanding shares in ROSG. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended September 2016, these large investors purchased a net $699.8 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SABBY CAPITAL LLC Bought 591.3 Thousand shares of Rosetta Genomics Ltd
MORGAN STANLEY & CO. LLC Bought 116.4 Thousand shares of Rosetta Genomics Ltd